721 related articles for article (PubMed ID: 15477656)
21. The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice.
Cardell SL
Clin Exp Immunol; 2006 Feb; 143(2):194-202. PubMed ID: 16412042
[TBL] [Abstract][Full Text] [Related]
22. Dissociation of NKT stimulation, cytokine induction, and NK activation in vivo by the use of distinct TCR-binding ceramides.
Ortaldo JR; Young HA; Winkler-Pickett RT; Bere EW; Murphy WJ; Wiltrout RH
J Immunol; 2004 Jan; 172(2):943-53. PubMed ID: 14707067
[TBL] [Abstract][Full Text] [Related]
23. Innate Valpha14(+) natural killer T cells mature dendritic cells, leading to strong adaptive immunity.
Fujii S; Shimizu K; Hemmi H; Steinman RM
Immunol Rev; 2007 Dec; 220():183-98. PubMed ID: 17979847
[TBL] [Abstract][Full Text] [Related]
24. Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes.
Burdin N; Brossay L; Koezuka Y; Smiley ST; Grusby MJ; Gui M; Taniguchi M; Hayakawa K; Kronenberg M
J Immunol; 1998 Oct; 161(7):3271-81. PubMed ID: 9759842
[TBL] [Abstract][Full Text] [Related]
25. Immunization with alpha-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis.
Burdin N; Brossay L; Kronenberg M
Eur J Immunol; 1999 Jun; 29(6):2014-25. PubMed ID: 10382765
[TBL] [Abstract][Full Text] [Related]
26. The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice.
Hong S; Wilson MT; Serizawa I; Wu L; Singh N; Naidenko OV; Miura T; Haba T; Scherer DC; Wei J; Kronenberg M; Koezuka Y; Van Kaer L
Nat Med; 2001 Sep; 7(9):1052-6. PubMed ID: 11533710
[TBL] [Abstract][Full Text] [Related]
27. Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon gamma production.
Ikarashi Y; Mikami R; Bendelac A; Terme M; Chaput N; Terada M; Tursz T; Angevin E; Lemonnier FA; Wakasugi H; Zitvogel L
J Exp Med; 2001 Oct; 194(8):1179-86. PubMed ID: 11602646
[TBL] [Abstract][Full Text] [Related]
28. The immunoregulatory role of CD1d-restricted natural killer T cells in disease.
van der Vliet HJ; Molling JW; von Blomberg BM; Nishi N; Kölgen W; van den Eertwegh AJ; Pinedo HM; Giaccone G; Scheper RJ
Clin Immunol; 2004 Jul; 112(1):8-23. PubMed ID: 15207777
[TBL] [Abstract][Full Text] [Related]
29. CD1d is expressed on B-chronic lymphocytic leukemia cells and mediates alpha-galactosylceramide presentation to natural killer T lymphocytes.
Fais F; Morabito F; Stelitano C; Callea V; Zanardi S; Scudeletti M; Varese P; Ciccone E; Grossi CE
Int J Cancer; 2004 Apr; 109(3):402-11. PubMed ID: 14961579
[TBL] [Abstract][Full Text] [Related]
30. CD1d-restricted NKT cell activation enhanced homeostatic proliferation of CD8+ T cells in a manner dependent on IL-4.
Ueda N; Kuki H; Kamimura D; Sawa S; Seino K; Tashiro T; Fushuku K; Taniguchi M; Hirano T; Murakami M
Int Immunol; 2006 Sep; 18(9):1397-404. PubMed ID: 16914507
[TBL] [Abstract][Full Text] [Related]
31. CD1d-restricted help to B cells by human invariant natural killer T lymphocytes.
Galli G; Nuti S; Tavarini S; Galli-Stampino L; De Lalla C; Casorati G; Dellabona P; Abrignani S
J Exp Med; 2003 Apr; 197(8):1051-7. PubMed ID: 12695492
[TBL] [Abstract][Full Text] [Related]
32. Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis.
Mallevaey T; Fontaine J; Breuilh L; Paget C; Castro-Keller A; Vendeville C; Capron M; Leite-de-Moraes M; Trottein F; Faveeuw C
Infect Immun; 2007 May; 75(5):2171-80. PubMed ID: 17353286
[TBL] [Abstract][Full Text] [Related]
33. CD1d-dependent activation of NKT cells aggravates atherosclerosis.
Tupin E; Nicoletti A; Elhage R; Rudling M; Ljunggren HG; Hansson GK; Berne GP
J Exp Med; 2004 Feb; 199(3):417-22. PubMed ID: 14744994
[TBL] [Abstract][Full Text] [Related]
34. CD4 engagement by CD1d potentiates activation of CD4+ invariant NKT cells.
Thedrez A; de Lalla C; Allain S; Zaccagnino L; Sidobre S; Garavaglia C; Borsellino G; Dellabona P; Bonneville M; Scotet E; Casorati G
Blood; 2007 Jul; 110(1):251-8. PubMed ID: 17363727
[TBL] [Abstract][Full Text] [Related]
35. Natural killer T cells as targets for therapeutic intervention in autoimmune diseases.
Wilson MT; Van Kaer L
Curr Pharm Des; 2003; 9(3):201-20. PubMed ID: 12570826
[TBL] [Abstract][Full Text] [Related]
36. [A specific ligand of V alpha 14 NKT cells and its presentation].
Harada M; Taniguchi M
Tanpakushitsu Kakusan Koso; 2003 Jun; 48(8 Suppl):1126-32. PubMed ID: 12807019
[No Abstract] [Full Text] [Related]
37. Role of γδ T cells in α-galactosylceramide-mediated immunity.
Paget C; Chow MT; Duret H; Mattarollo SR; Smyth MJ
J Immunol; 2012 Apr; 188(8):3928-39. PubMed ID: 22412194
[TBL] [Abstract][Full Text] [Related]
38. Glycosylphosphatidylinositol-anchored mucin-like glycoproteins from Trypanosoma cruzi bind to CD1d but do not elicit dominant innate or adaptive immune responses via the CD1d/NKT cell pathway.
Procópio DO; Almeida IC; Torrecilhas AC; Cardoso JE; Teyton L; Travassos LR; Bendelac A; Gazzinelli RT
J Immunol; 2002 Oct; 169(7):3926-33. PubMed ID: 12244192
[TBL] [Abstract][Full Text] [Related]
39. Going both ways: immune regulation via CD1d-dependent NKT cells.
Godfrey DI; Kronenberg M
J Clin Invest; 2004 Nov; 114(10):1379-88. PubMed ID: 15545985
[TBL] [Abstract][Full Text] [Related]
40. Production and characterization of monoclonal antibodies against complexes of the NKT cell ligand alpha-galactosylceramide bound to mouse CD1d.
Yu KO; Im JS; Illarionov PA; Ndonye RM; Howell AR; Besra GS; Porcelli SA
J Immunol Methods; 2007 May; 323(1):11-23. PubMed ID: 17442335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
